Search
for
Sort by
Research 121–150 of 1000+
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Baricitinib: From Rheumatoid Arthritis to COVID‐19
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- New drugs under investigation for the treatment of alopecias
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Janus kinase inhibitors for alopecia areata
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Ruxolitinib for the treatment of severe alopecia areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1